Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
01 2Honour Lab Limited
02 2Dr. Reddy's Laboratories Limited
03 1Dr. Reddy¿s Laboratories Limited
04 1Metrochem API Private Limited
05 1Cohance Lifesciences Limited
06 1Aurobindo Pharma Limited
07 1Bidachem S.p.a.
08 1Biocon Limited
09 3Boehringer Ingelheim Pharma GmbH and Co. KG
10 1Cipla Ltd.
11 1Dr. Reddy's Laboratories Ltd.
12 1EMNAR PHARMA PRIVATE LIMITED
13 2MSN Life Sciences Private Limited
14 1Qingdao Biopeptek Co., Ltd.
15 1SMS Pharmaceuticals Limited
16 1Tianish Laboratories Private Limited
17 1USV Private Limited
18 2ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
01 18Empagliflozin
02 1Empagliflozin (Process II)
03 3Empagliflozin Amorphous
04 2Jardiance
01 2China
02 3Germany
03 16India
04 1Italy
05 1U.S.A
06 1Blank
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
NDC Package Code : 69037-0029
Start Marketing Date : 2014-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-001
Start Marketing Date : 2018-01-02
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-016
Start Marketing Date : 2020-10-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1015
Start Marketing Date : 2019-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
NDC Package Code : 69037-0033
Start Marketing Date : 2014-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-048
Start Marketing Date : 2022-03-30
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-064
Start Marketing Date : 2022-12-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12714-201
Start Marketing Date : 2016-02-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12714-920
Start Marketing Date : 2014-08-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25mg/25mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 12714-930
Start Marketing Date : 2014-08-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10mg/10mg)
Marketing Category : DRUG FOR FURTHER PROCESSING
46
PharmaCompass offers a list of Empagliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Empagliflozin manufacturer or Empagliflozin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Empagliflozin manufacturer or Empagliflozin supplier.
PharmaCompass also assists you with knowing the Empagliflozin API Price utilized in the formulation of products. Empagliflozin API Price is not always fixed or binding as the Empagliflozin Price is obtained through a variety of data sources. The Empagliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BI 10773 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BI 10773, including repackagers and relabelers. The FDA regulates BI 10773 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BI 10773 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BI 10773 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A BI 10773 supplier is an individual or a company that provides BI 10773 active pharmaceutical ingredient (API) or BI 10773 finished formulations upon request. The BI 10773 suppliers may include BI 10773 API manufacturers, exporters, distributors and traders.
click here to find a list of BI 10773 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing BI 10773 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for BI 10773 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture BI 10773 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain BI 10773 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a BI 10773 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of BI 10773 suppliers with NDC on PharmaCompass.
We have 16 companies offering BI 10773
Get in contact with the supplier of your choice:
